E-mail this page Printer Friendly Version RSS E-mail Alerts View contacts Download Financial Tear Sheet 

2010 Press Releases

This section of the website contains information that should be considered accurate as of the date presented. You acknowledge that this information may change over time and you should not assume that the information is accurate at a later date. Quest Diagnostics is not obligated to update the information contained in this section of the website.

Keyword Search
 
2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007
DateTitle 
12/20/10Pregnant Women Are Not Screened Adequately for Gestational Diabetes, Obstetrics and Gynecology Study Finds
Study also finds nearly one in five women with gestational diabetesare not screened for diabetes postpartum MADISON, N.J., Dec. 20, 2010 /PRNewswire via COMTEX/ --Nearly one third of pregnant women are not being screened by a simple laboratory test for gestational diabetes mellitus (gestational diabetes), according to a study of more than 900,000 American women published online today in Obstetrics and Gynecology. The study, conducted by scientists at Quest Diagnostics (NYSE: DGX), suggests th... 
Printer Friendly Version
12/16/10Quest Diagnostics(R) Care360(TM) EHR Receives ONC-ATCB 2011/2012 Certification
MADISON, N.J., Dec. 16, 2010 /PRNewswire via COMTEX/ --Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, today announced that its Care360(TM) Electronic Health Record (EHR), Version 2010.2, is 2011/2012 compliant and was certified as a Complete EHR on Wednesday, December 15, 2010, by the Certification Commission for eligible Health Information Technology (CCHIT(R)), an ONC-ATCB, in accordance with the applicable eligible provider certifi... 
Printer Friendly Version
12/02/10Quest Diagnostics Declares Quarterly Cash Dividend
MADISON, N.J., Dec. 2, 2010 /PRNewswire via COMTEX/ --Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, today announced that its Board of Directors declared a quarterly cash dividend of $0.10 per share, payable on January 25, 2011, to shareholders of record of Quest Diagnostics common stock on January 10, 2011. About Quest Diagnostics Quest Diagnostics is the world's leading provider of diagnostic testing, informatio... 
Printer Friendly Version
12/01/10FDA Clears Influenza and Respiratory Virus Test Kit from Quest Diagnostics' Focus Diagnostics Business
Simplexa(TM) is first molecular test kit that does not require additional testing to confirm flu A, flu B or respiratory syncytial virus (RSV) infection MADISON, N.J., and CYPRESS, Calif., Dec. 1, 2010 /PRNewswire via COMTEX/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, today announced that the U.S. Food and Drug Administration (FDA) has issued 510(k) clearance to the Focus Diagnostics Simplexa Flu A/B & RSV te... 
Printer Friendly Version
11/23/10New Study Questions Value of Expanded Genetic Testing for Cystic Fibrosis
Eight-year study in Genetics in Medicine shows core mutation panel reliably detects carriers MADISON, N.J., Nov. 23, 2010 /PRNewswire via COMTEX/ --Testing for genetic mutations beyond those medically recommended is unlikely to prevent the birth of children with classic cystic fibrosis and may detect mutations causing only mild disease, according to a study published online in Genetics in Medicine, the official publication of the American College of Medical Genetics (ACMG).The findings raise ... 
Printer Friendly Version
11/16/10Quest Diagnostics to Speak at the Lazard Capital Markets 7th Annual Healthcare Conference
MADISON, N.J., Nov. 16, 2010 /PRNewswire via COMTEX/ --Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced that it is scheduled to speak at the Lazard Capital Markets 7th Annual Healthcare Conference in New York City. The presentation is scheduled for Wednesday, November 17, 2010 at 8:30 a.m. Eastern Time. During the conference, the company will reaffirm its 2010 guidance. The company expects revenues to be appr... 
Printer Friendly Version
10/28/10Quest Diagnostics Introduces Gazelle(TM) Secure Mobile Health Platform
- First Mobile Health Platform From A Diagnostic Testing Company - Empowers Patients To Actively Manage And Take Personal Accountability For Their Health - Direct Patient Access To Quest Diagnostics Lab Results In 33 States - A Gateway That Welcomes Third Party Application Developers MADISON, N.J., Oct 28, 2010 /PRNewswire via COMTEX/ --Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, today introduced Gazelle, a secure mobile heal... 
Printer Friendly Version
10/20/10Quest Diagnostics Reports Third Quarter 2010 Financial Results; Updates Guidance for 2010
- Diluted EPS of $1.13, 11% above 2009 - Revenues of $1.9 billion, 1.7% below 2009 - Cash flow from operations of $330 million - Full year guidance before special items: Diluted EPS between $3.95 and $4.00; revenues approximately 1.5% below prior year - Board authorizes new $250 million share repurchase program MADISON, N.J., Oct 20, 2010 /PRNewswire via COMTEX/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, anno... 
Printer Friendly Version
10/20/10Quest Diagnostics Increases Share Repurchase Authority By $250 Million
MADISON, N.J., Oct 20, 2010 /PRNewswire via COMTEX/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced that its Board of Directors increased the company's share repurchase authorization by $250 million. During the first three quarters of 2010, the company repurchased approximately 15 million shares of common stock for $750 million, fully utilizing its previous authorization, which was granted in January, 2010. ... 
Printer Friendly Version
10/15/10American Medical Association To Offer Quest Diagnostics Care360(TM) EHR On Its New Online Physician Platform
Care360 EHR Offers Physicians Affordable Health Information Technology to Meet Clinical and Practice Needs and Help Demonstrate Meaningful Use MADISON, N.J., Oct 15, 2010 /PRNewswire via COMTEX/ --Quest Diagnostics' (NYSE: DGX) healthcare information (IT) technology subsidiary MedPlus and the American Medical Association (AMA), the nation's largest physician organization, today announced they are partnering to expand the adoption of health information technology by offering Care360(TM) EHR, a... 
Printer Friendly Version
10/05/10Quest Diagnostics and HP Simplify Electronic Health Records for Physician Practices
Companies Offer Comprehensive EHR Solutions to Accelerate Adoption Including a Nationwide Tour to Educate Small Physician Practices MADISON, N.J., Oct 05, 2010 /PRNewswire via COMTEX/ --Quest Diagnostics' (NYSE: DGX) health information technology subsidiary MedPlus and HP today announced they are partnering to facilitate and simplify electronic health record (EHR) adoption for physician practices nationwide. Quest Diagnostics' web-based Care360(TM) EHR software and services coupled with ... 
Printer Friendly Version
09/28/10Quest Diagnostics to Release Third Quarter 2010 Financial Results
MADISON, N.J., Sept 28, 2010 /PRNewswire via COMTEX/ --Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced today that it will report third quarter 2010 results on Wednesday, October 20, before the market opens. It will hold its quarterly conference call with investors to discuss the results beginning at 8:30 a.m. ET on that day. The public may access the conference call through a live audio webcast available on ... 
Printer Friendly Version
09/16/10U.S. Worker Use of Prescription Opiates Climbing, Shows Quest Diagnostics Drug Testing Index(TM)
Post-accident tests find opiates up to four times more than pre-employment tests MADISON, N.J., Sept 16, 2010 /PRNewswire via COMTEX/ --More American workers and job applicants are testing positive for prescription opiates, according to U.S. general workforce data in the 2009 annual Drug Testing Index(TM) (DTI) released today by Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services.Results from more than 5.5 million urine dru... 
Printer Friendly Version
09/10/10Quest Diagnostics Marks Seventh Year on Dow Jones Sustainability Index
Company Named to Both World and North American Indexes MADISON, N.J., Sept 10, 2010 /PRNewswire via COMTEX/ --Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, today announced that it has again been selected to be part of the Dow Jones Sustainability World Indexes and North America Indexes (DJSI World and DJSI North America). The company is in its seventh year on the World Index (since 2004) and in its sixth on the North ... 
Printer Friendly Version
08/23/10Quest Diagnostics' Care360(TM) EHR Module Receives Preliminary ARRA IFR Stage 1 Certification
MADISON, N.J., Aug 23, 2010 /PRNewswire via COMTEX/ --Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, today announced that its Care360(TM) Electronic Health Record (EHR), Version 2010.1, has been inspected by the Certification Commission for Health Information Technology (CCHIT(R)) and is a certified EHR Module, IFR Stage 1, achieving all 14 of the requirements applied for of the 24 requirements for Eligible Providers published by the ... 
Printer Friendly Version
08/11/10Quest Diagnostics Declares Quarterly Cash Dividend
MADISON, N.J., Aug 11, 2010 /PRNewswire via COMTEX/ --Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, today announced that its Board of Directors declared a quarterly cash dividend of $0.10 per share, payable on October 19, 2010, to shareholders of record of Quest Diagnostics common stock on October 4, 2010. About Quest Diagnostics Quest Diagnostics is the world's leading provider of diagnostic testing, information ... 
Printer Friendly Version
07/28/10New York State Approves Quest Diagnostics' Fragile X Syndrome Test
XSense(R) is the first laboratory test that may be suitable for population-based screening for Fragile X Syndrome, the leading inherited cause of mental retardation MADISON, N.J., July 28, 2010 /PRNewswire via COMTEX/ --An accurate, faster testing option to identify female carriers and other patients with genetic abnormalities that cause Fragile X Syndrome is now available to physicians in all fifty states with the recent approval in New York. Fragile X is the leading cause of inherited menta... 
Printer Friendly Version
07/21/10Quest Diagnostics Reports Second Quarter 2010 Financial Results; Updates Guidance for 2010
- Diluted earnings per share of $1.07, 7% above 2009 - Revenues of $1.9 billion, 1.4% below 2009 - Full year EPS expected to be between $3.90 and $4.00; full year revenues expected to be approximately 1% below prior year MADISON, N.J., July 21, 2010 /PRNewswire via COMTEX/ --Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced that for the second quarter ended June 30, 2010, income from continuing operations incr... 
Printer Friendly Version
07/14/10Quest Diagnostics To Release Second Quarter 2010 Financial Results
MADISON, N.J., July 14, 2010 /PRNewswire via COMTEX/ --Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced today that it will report second quarter 2010 results on Wednesday, July 21, before the market opens. It will hold its quarterly conference call with investors to discuss the results beginning at 8:30 a.m. ET on that day. The public may access the conference call through a live audio webcast available on Qu... 
Printer Friendly Version
06/14/10Quest Diagnostics Again Earns Platinum Honor As 'Best Employer For Healthy Lifestyles'
National Business Group on Health Recognizes HealthyQuest Program for Sixth Straight Year WASHINGTON, and MADISON, N.J., June 14, 2010 /PRNewswire via COMTEX/ --The National Business Group on Health (NBGH) has awarded its 2010 Best Employers for Healthy Lifestyles Platinum Award to Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services. The 2010 award, in recognition of the company's HealthyQuest employee wellness initiative, m... 
Printer Friendly Version
06/09/10Quest Diagnostics to Speak at the William Blair & Company 30th Annual Growth Stock Conference
MADISON, N.J., June 9, 2010 /PRNewswire via COMTEX/ --Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced that it is scheduled to speak at the William Blair & Company 30th Annual Growth Stock Conference in Chicago. The presentation is scheduled for Tuesday, June 15, 2010 at 10:10 a.m. Central Time. The presentation will be webcast live during the conference and will be available to registered investors on the... 
Printer Friendly Version
05/24/10First FDA Clearance of a 2009 H1N1 Test Given to Quest Diagnostics' Focus Diagnostics Business
Simplexa(TM) molecular RT-PCR test runs on the 3M Integrated Cycler MADISON, N.J., and CYPRESS, Calif., May 24, 2010 /PRNewswire via COMTEX/ --Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, today announced that the U.S. Food and Drug Administration (FDA) has issued 510(k) clearance to the Simplexa(TM) Influenza A H1N1 (2009) test on the 3M(TM) Integrated Cycler. The Simplexa test, developed and manufactured by Quest Di... 
Printer Friendly Version
05/21/10ONC Recognizes New Mexico as First State to Successfully Obtain HIE Implementation Funds
Federal Funds and MedPlus Centergy Solution Accelerate New Mexico Health Information Collaborative's (NMHIC) Plan to Serve Two Million Patients Statewide ALBUQUERQUE, N.M., May 21, 2010 /PRNewswire via COMTEX/ --New Mexico is the first state to meet all requirements for strategic and operational planning as part of the American Recovery and Reinvestment Act (ARRA) state health information exchange (HIE) cooperative agreement program, according to the United States Office of the National Coord... 
Printer Friendly Version
05/06/10Quest Diagnostics Declares Quarterly Cash Dividend
MADISON, N.J., May 6, 2010 /PRNewswire via COMTEX/ --Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, today announced that its Board of Directors declared a quarterly cash dividend of $0.10 per share, payable on July 20, 2010, to shareholders of record of Quest Diagnostics common stock on July 6, 2010. About Quest Diagnostics Quest Diagnostics is the world's leading provider of diagnostic testing, information and servic... 
Printer Friendly Version
04/29/10H1N1 Crowds Out Other Flu Viruses, Higher Positive Trends in Children Tested
The Quest Diagnostics Health Trends(TM) Report analyzes 195,000 H1N1 test results performed nationally since May 2009 MADISON, N.J., April 29, 2010 /PRNewswire via COMTEX/ --More than 99 percent of specimens tested for influenza were positive for H1N1 over approximately the past 11 months, according to a report released today from Quest Diagnostics Incorporated (NYSE: DGX). The Quest Diagnostics Health Trends(TM) Report suggests that H1N1 "crowded out" other influenza viruses to be the domina... 
Printer Friendly Version
04/21/10Quest Diagnostics Reports First Quarter 2010 Financial Results; Updates Guidance for 2010
- Diluted earnings per share of $0.89, and revenues of $1.8 billion, unchanged from 2009 - 2010 adjusted EPS guidance unchanged at between $4.10 and $4.30 - On a reported basis, 2010 EPS guidance is expected to be between $4.00 and $4.20 MADISON, N.J., April 21, 2010 /PRNewswire via COMTEX/ --Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced that for the first quarter ended March 31, 2010, income from continu... 
Printer Friendly Version
04/12/10Quest Diagnostics Moves Start of April 21 Financial Conference Call to 8 am ET
MADISON, N.J., April 12, 2010 /PRNewswire via COMTEX/ --Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced today that it has moved the start of its quarterly conference call scheduled for Wednesday, April 21, to 8 a.m. ET. The company had previously scheduled the call to begin at 8:30 a.m. ET on that day. The company plans to report first-quarter 2010 financial results earlier that morning. The public may access... 
Printer Friendly Version
04/06/10Quest Diagnostics To Release First Quarter 2010 Financial Results
MADISON, N.J., April 6, 2010 /PRNewswire via COMTEX/ --Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced today that it will report first-quarter 2010 results on Wednesday, April 21, before the market opens. It will hold its quarterly conference call with investors to discuss the results beginning at 8:30 a.m. ET on that day. The public may access the conference call through a live audio webcast available on Ques... 
Printer Friendly Version
04/01/10Quest Diagnostics Honored by CEO Roundtable on Cancer
Company Granted CEO Gold Standard(TM) Accreditation for Its Commitment to Employee Health and the Fight Against Cancer MADISON, N.J., April 1, 2010 /PRNewswire via COMTEX/ --Quest Diagnostics Incorporated (NYSE: DGX), the world's leader in cancer diagnostics, announced today that the company has received CEO Cancer Gold Standard accreditation(TM) from The CEO Roundtable on Cancer. This prestigious designation recognizes Quest Diagnostics for taking important actions to reduce the cancer risk ... 
Printer Friendly Version
03/17/10Health Discovery Corporation and Smart Personalized Medicine Form Agreement for Developing Laboratory Tests for Breast Cancer Therapy Selection with Quest Diagnostics
SAVANNAH, Ga. & MILFORD, Del., Mar 17, 2010 (BUSINESS WIRE) -- Health Discovery Corporation (OTCBB: HDVY) (HDC) and Smart Personalized Medicine, LLC (SPM) announced today that they have entered into development and related licensing agreements with Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services. Under the agreements, Quest Diagnostics will develop new laboratory tests for aiding in the selection of breast cancer therapies.... 
Printer Friendly Version
03/16/10Quest Diagnostics To Speak at the Barclays Capital Global Healthcare Conference
MADISON, N.J., March 16, 2010 /PRNewswire via COMTEX/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced that it is scheduled to speak at the Barclays Capital Global Healthcare Conference in Miami. The presentation is scheduled for Wednesday, March 24, 2010 at 9:00 a.m. Eastern Time. The presentation will be webcast live during the conference and will be available to registered investors on the following site: ... 
Printer Friendly Version
03/09/10OVA1 Blood Test Now Available to Aid Pre-surgical Evaluation of Women for Ovarian Cancer
FDA-cleared test helps direct women to the most appropriate surgeon, promoting better outcomesMADISON, N.J. and FREMONT, Calif., March 9, 2010 /PRNewswire via COMTEX/ -- OVA1(TM), the first blood test cleared by the U.S. Food and Drug Administration (FDA) for aiding in the pre-surgical evaluation of a woman's ovarian mass for cancer, is now available nationally through Quest Diagnostics, Inc. (NYSE: DGX), the world's leading cancer diagnostics provider. With the availability of OVA1, physicians ... 
Printer Friendly Version
03/05/10Quest Diagnostics Ranked Among FORTUNE Magazine's 'World's Most Admired Companies' For Third Consecutive Year
Company also ranked among top 100 Best Corporate Citizens by Corporate Responsibility MagazineMADISON, N.J., March 5, 2010 /PRNewswire via COMTEX/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced today that it has been included on FORTUNE magazine's 2010 "World's Most Admired Companies" list. Quest Diagnostics ranked third in the "Health Care" industry category of "Pharmacy and Other Services." The 2010 ranking... 
Printer Friendly Version
03/04/10Quest Diagnostics and Surescripts to Pioneer Integrated Service Combining Lab and Prescription Information to Improve Patient Safety and Clinical Outcomes
ATLANTA, March 4, 2010 /PRNewswire via COMTEX/ -- Two of the nation's largest healthcare information networks, Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, and Surescripts(R), The Nation's E-Prescription Network(TM), today announced an agreement to pioneer the formation of an integrated service to make laboratory and prescription information broadly and easily accessible to physicians. The collaboration is designed to improve patien... 
Printer Friendly Version
03/01/10Quest Diagnostics to Speak at the RBC Capital Markets 2010 Healthcare Conference
MADISON, N.J., March 1, 2010 /PRNewswire via COMTEX/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced that it is scheduled to speak at the RBC Capital Markets 2010 Healthcare Conference in New York City. The presentation is scheduled for Wednesday, March 3, 2010 at 9:00 a.m. Eastern Time. During the conference, the company will reaffirm its 2010 guidance for revenue growth of 3% to 4%, operating income to app... 
Printer Friendly Version
03/01/10Quest Diagnostics Unveils Care360(TM) EHR
--Company Empowers Physicians to Embrace Digital Healthcare, Connect with Peers, and Work Toward Meaningful Use One Step at a Time --90-Day Free Trial for Web-based Care360 EHR and Care360 ePrescribing Introduced at HIMSS10MADISON, N.J., March 1, 2010 /PRNewswire via COMTEX/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, today introduced Care360(TM) EHR (Electronic Health Record), the next evolution of its innovative C... 
Printer Friendly Version
02/11/10Quest Diagnostics Declares Quarterly Cash Dividend
MADISON, N.J., Feb 11, 2010 /PRNewswire via COMTEX/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, today announced that its Board of Directors declared a quarterly cash dividend of $0.10 per share, payable on April 20, 2010, to shareholders of record of Quest Diagnostics common stock on April 6, 2010. About Quest Diagnostics Quest Diagnostics is the world's leading provider of diagnostic testing, information and ser... 
Printer Friendly Version
02/05/10Quest Diagnostics to Speak at the UBS Global Healthcare Services Conference
MADISON, N.J., Feb 05, 2010 /PRNewswire via COMTEX/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced that it is scheduled to speak at the UBS 2010 Global Healthcare Services Conference in New York City. The presentation is scheduled for Wednesday, February 10, 2010 at 9:00 a.m. Eastern Time. During the conference, the company will reaffirm its 2010 guidance for revenue growth of 3% to 4%, operating income to... 
Printer Friendly Version
01/25/10Quest Diagnostics Reports Strong Performance for Fourth Quarter and Full Year 2009; Provides Guidance for 2010
- Fourth quarter diluted EPS grew 11% on revenue growth of 2.7%; cash from operations totaled $360 million - Full year diluted EPS grew 20% on revenue growth of 2.8%; cash from operations totaled $1 billion - 2010 EPS expected to be between $4.10 and $4.30 per diluted shareMADISON, N.J., Jan 25, 2010 /PRNewswire via COMTEX/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced that for the fourth quarter ended Dece... 
Printer Friendly Version
01/25/10Quest Diagnostics Increases Share Repurchase Authority By $750 Million
MADISON, N.J., Jan 25, 2010 /PRNewswire via COMTEX/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced that its Board of Directors increased the company's share repurchase authorization by $750 million. "The expansion of our share repurchase program reflects the company's financial strength and our ability to continue generating strong cash flows, and, in addition to continuing to invest in the growth of our bu... 
Printer Friendly Version
01/19/10Quest Diagnostics To Speak at the Jefferies 2010 Global Healthcare Services Conference
MADISON, N.J., Jan 19, 2010 /PRNewswire via COMTEX/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced that it is scheduled to speak at the Jefferies 2010 Global Healthcare Services Conference in New York City. The presentation is scheduled for Tuesday, January 26, 2010 at 9:30 a.m. Eastern Time. The presentation will be webcast live during the conference and will be available to registered investors on the fol... 
Printer Friendly Version
01/11/10Quest Diagnostics Introduces Molecular Blood Test for Aiding Colorectal Cancer Detection
MADISON, N.J., Jan 11, 2010 /PRNewswire via COMTEX/ -- A new blood test that identifies changes in DNA associated with colorectal cancer is now available in the U.S. through Quest Diagnostics Incorporated (NYSE: DGX), the world's leading cancer diagnostics company. The test is designed to aid the detection of colorectal cancer, the third leading cause of cancer-related deaths. The new test is based on DNA methylation of the Septin9 gene, a proprietary biomarker associated with colorectal cance... 
Printer Friendly Version
01/08/10Quest Diagnostics To Release Fourth Quarter and Full Year 2009 Financial Results
MADISON, N.J., Jan 08, 2010 /PRNewswire via COMTEX/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced today that it will report fourth-quarter and full year 2009 results and provide financial guidance for 2010 on Monday, January 25, before the market opens. It will hold its quarterly conference call with investors to discuss the results beginning at 8:30 a.m. ET on that day. The public may access the conferenc... 
Printer Friendly Version